NCT04064073

Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)

A Randomized, Open Label, Single / Multiple Dose, Crossover Phase 1, Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 34 (actual)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: Male
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate drug-drug interaction of DWP16001 in combination with metformin IR 1000mg in Healthy male subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DWP16001	Tablets, Oral, once daily single dose
DRUG	Metformin IR	Metformin IR 1000mg, Tablets, Oral, BID for 7 days
DRUG	DWP16001+Metformin IR	Tablets, Oral, once daily single dose DWP16001 Metformin IR 1000mg

Timeline

• Start date: 2019-08-14
• Primary completion: 2019-11-20
• Completion: 2019-11-20
• First posted: 2019-08-21
• Last updated: 2020-01-13

Locations

1 site across 1 country: South Korea